FRANKFURT (Reuters) -Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to ...

The EU has recently approved the use of glyphosate for another decade. Bárbara Pinho examines the controversial pesticide's ...

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against ...

Recent health news highlights include Bayer's optimism over Georgia's new law against glyphosate litigation, AstraZeneca's $1 ...

FRANKFURT, March 17 (Reuters) - Bayer (BAYGn.DE), opens new tab said ... protect the maker of crop protection chemicals against glyphosate litigation. The company said in a statement to Reuters ...

Bill Anderson, the CEO of Bayer, which now owns Monsanto, the maker of glyphosate, wants the next farm bill to include ...

Current health news highlights include Bayer's support for a new U.S. law on glyphosate litigation, WHO's warning on Afghan healthcare funding shortages, and AstraZeneca's $1 billion acquisition of ...

Ongoing glyphosate litigation trend is positive; remaining court case settlements are anticipated but more than accounted for in valuation. Bayer’s pharmaceutical division generates ~€18 ...

Bayer has paid about $10 billion to settle disputed claims that Roundup, based on the herbicide glyphosate, causes cancer. About 67,000 further cases are pending for which the group has set aside ...

Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product ...

German pharmaceutical and biotechnology group, Bayer, has told the US government that it would have to stop selling its ...